Correction to: Clinical prognostic value of different NPM1 mutations in acute myeloid leukemia patients.

Autor: Shi Y; Department of Hematology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.; Key Laboratory of Hematology, Nanjing Medical University, Nanjing, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China., Chen X; Department of Hematology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.; Key Laboratory of Hematology, Nanjing Medical University, Nanjing, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China., Jin H; Department of Hematology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.; Key Laboratory of Hematology, Nanjing Medical University, Nanjing, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China., Zhu L; Department of Hematology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.; Key Laboratory of Hematology, Nanjing Medical University, Nanjing, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China., Hong M; Department of Hematology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.; Key Laboratory of Hematology, Nanjing Medical University, Nanjing, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China., Zhu Y; Department of Hematology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.; Key Laboratory of Hematology, Nanjing Medical University, Nanjing, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China., Wu Y; Department of Hematology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.; Key Laboratory of Hematology, Nanjing Medical University, Nanjing, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China., Qiu H; Department of Hematology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.; Key Laboratory of Hematology, Nanjing Medical University, Nanjing, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China., Wang Y; Department of Hematology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.; Key Laboratory of Hematology, Nanjing Medical University, Nanjing, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China., Sun Q; Department of Hematology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.; Key Laboratory of Hematology, Nanjing Medical University, Nanjing, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China., Jin H; Department of Hematology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.; Key Laboratory of Hematology, Nanjing Medical University, Nanjing, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China., Li J; Department of Hematology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.; Key Laboratory of Hematology, Nanjing Medical University, Nanjing, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China., Qian S; Department of Hematology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. qiansx@medmail.com.cn.; Key Laboratory of Hematology, Nanjing Medical University, Nanjing, China. qiansx@medmail.com.cn.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China. qiansx@medmail.com.cn., Qiao C; Department of Hematology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. qiaochun001004@163.com.; Key Laboratory of Hematology, Nanjing Medical University, Nanjing, China. qiaochun001004@163.com.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China. qiaochun001004@163.com.
Jazyk: angličtina
Zdroj: Annals of hematology [Ann Hematol] 2024 Aug; Vol. 103 (8), pp. 3281.
DOI: 10.1007/s00277-024-05812-x
Databáze: MEDLINE